Search results

Filters

  • Journals
  • Authors
  • Keywords
  • Date
  • Type

Search results

Number of results: 6
items per page: 25 50 75
Sort by:
Download PDF Download RIS Download Bibtex

Abstract

Placoid and polyodontode scales of stem chondrichthyans have been found in the early Lochkovian “Ditton

Group” of the Brown Clee Hill district, Shropshire, England and at Talgarth, south Wales. One of the forms is

assigned to a new species of Altholepis Karatajūtė-Talimaa, 1997, a genus already recognised from Lochkovian

shallow marine deposits in Celtiberia, Spain and the Northwest Territories, Canada as well as the type locality in

Podolia, Ukraine. Altholepis salopensis sp. nov. is based on small polyodontode scales with typically three to eight

high odontodes; the scale form was previously considered to belong to acanthodian “Nostolepis” robusta (Brotzen,

1934). The structure of other scales formerly assigned to “Nostolepis” robusta has led us to erect a new genus

Jolepis for this scale form, which differs from Altholepis in lacking an ordered layout of odontodes. Jolepis robusta

(Brotzen, 1934), originally (and possibly still) considered to be an acanthodian, is also known from the Baltic

countries, Russia, and northern Germany (ex erratic limestones). Scales of acanthodian Parexus recurvus Agassiz,

1845, and/or possibly from the stem chondrichthyan Seretolepis elegans Karatajūtė-Talimaa, 1968 (scales of these

two taxa are barely distinguishable), and of stem chondrichthyan Polymerolepis whitei Karatajūtė-Talimaa, 1968

are also present. Altholepis, Jolepis gen. nov., Seretolepis Karatajūtė-Talimaa, 1968 and Polymerolepis Karatajūtė-

Talimaa, 1968 are found in marine deposits elsewhere; the British occurrence of these taxa adds to the debate on

the sedimentological origins of the Lower Old Red Sandstone deposits in the Welsh Borderland. The geographic

range of several early sharks is now known to extend around the Old Red Sandstone continent and beyond.

Go to article

Authors and Affiliations

Carole J. Burrow
Susan Turner
Download PDF Download RIS Download Bibtex

Abstract

Artemisinin is a powerful antimalarial drug, useful in the treatment of many diseases, includ- ing chickens coccidiosis. Its toxic effects have been well studied in humans and experimental animals, but not sufficiently in broiler chickens. Therefore, in the present study, we aimed to assess the side effects of artemisinin in chickens, by measuring the serum level of proteins and enzymes (ALT, AST, GGT, ALP, CK), by histopathological examination and by the evaluation of relative weight of organs (liver, kidney, heart). Artemisinin was administered in the standard feed for chickens in three different concentrations: 5, 50 and 500 ppm.

Each concentration of artemisinin increased the total serum proteins, gamma-globulins and the serum activity of CK and decreased the serum ALP level. The values of ALT and GGT were higher in the chickens treated with 50 and 500 ppm of artemisinin. Multifocal liver necrosis and inflammatory infiltrate were detected in the chickens that received the 50 and 500 ppm dosage of artemisinin. Minimal tubular necrosis, renal tubular epithelium vacuolation, multifocal interstitial nephritis and mild uric nephrosis were detected in chickens treated with the drug. Artemisinin administration produced no significant changes in the organs relative weight.

Artemisinin, at a concentration of 5 mg/kg of feed is well tolerated by broiler chickens, but the concentrations of 50 and 500 mg/ kg feed can produce toxic effects.

Go to article

Authors and Affiliations

A. Gyӧrke
L.M. Pop
M. Mircean
Z. Kalmár
A.F. Tăbăran
A.I. Paștiu
M.O. Dumitrache
C. Magdaș
A. Balea
D. Bărburaș
V. Mircean
V. Cozma
Download PDF Download RIS Download Bibtex

Abstract

Resistance genes in response to root-knot nematode (Meloidogyne javanica) infection suppress one or more of several critical steps in nematode parasitism and their reproduction rate. The reaction of seven commercial tomato genotypes to M. javanica infection was investigated under greenhouse conditions. Current results classified these genotypes as: three resistant (Jampakt, Malika and Nema Guard), one moderately resistant (Fayrouz), and three susceptible (Castle Rock, Super Marmande and Super Strain B). Except Nema Guard, nematode infection significantly reduced plant height, fresh and dry weights of shoots of the other tomato genotypes. Leaf area was significantly reduced for all examined tomato genotypes except Malika and Nema Guard. Total chlorophyll was reduced in all tested tomato genotypes except Jampakt. Infection parameters of M. javanica and their population were significantly reduced on all nematode-resistant tomato genotypes compared to the susceptible genotypes. Also, the maturation rate of M. javanica was suppressed in the resistant genotypes compared to the susceptible genotypes. These results were confirmed by histological study that illustrated a delay in nematode development and their maturation. Total phenolic content significantly increased in nematode infected roots of both resistant and susceptible genotypes except Malika. Among non-infected roots, Malika showed the highest level of total phenols while after M. javanica infection, Nema Guard revealed the highest level of total phenols. Among infected roots, the highest level of total phenols was recorded in Castle Rock. These results suggested that using nematode-resistant tomato genotypes could provide an efficient and nonpolluting method to control root-knot nematodes.

Go to article

Authors and Affiliations

Mohamed Youssef Banora
Omar Abd Alhakim Almaghrabi
Download PDF Download RIS Download Bibtex

Abstract

The new rich collection of fossil fish remains obtained during the Polish Spitsbergen Expedition of 1998 includes many isolated shark teeth, mostly of the genera Lissodus, Hybodus and Acrodus. The shark microfossils from the Hornsund area (South Spitsbergen) described here and the analysis of the histology of Lissodus teeth contribute to a better understanding of the previously described Early Triassic fish fauna from that region (Birkenmajer and Jerzmańska 1979). There is the evidence for coexistence of two types of histology within a single taxon what closes the discussion considering ortho- and osteodentine as a taxonomic factor.

Go to article

Authors and Affiliations

Błażej Błażejowski
Download PDF Download RIS Download Bibtex

Abstract

Analysis of weathering parameters of bones from cave deposits is presented as a useful tool of palaeoenvironmental reconstruction. As an example, we studied profiles of sediments in two Palaeolithic sites: Nietoperzowa Cave and Deszczowa Cave. Our studies included histological and EDS analyses of bone remnants found in these profiles. This method allowed us to reconstruct the changes of palaeotemperature and palaeohumidity, and finally the climatostratigraphy of sediments. The results presented here put a new light onto the stratigraphy of Deszczowa Cave's filling. In particular, besides the Vistulian sediments (MIS 2-5d), we confirmed the presence oflayers formed during the Penultimate Glaciation (MIS 6) and Eemian Interglacial (MIS 5e).

Go to article

Authors and Affiliations

Maciej T. Krajcarz
Teresa Madeyska
Download PDF Download RIS Download Bibtex

Abstract

This study aimed to develop an equine-derived hyperimmune serum against SARS-CoV-2 and evaluate its efficacy as a potential immunotherapy tool for the treatment of known and potential variants of COVID-19 in preclinical trials.
The novelty of this study is the whole virus and ALUM gel adjuvant formula. The horses were immunized using a whole inactivated SARS-CoV-2 antigen, and the final purified hyperimmune serum showed high plaque reduction neutralization (PRNT 50) neutralizing titers. The efficacy of the hyperimmune serum was evaluated histopathologically and biochemically in the lungs, hearts, and serum of K18 hACE2 transgenic mice (n=45), which is an accepted model organism for SARS-CoV-2 studies and was challenged with live SARS-CoV-2.
Serum treatment improved the general condition, resulting in lower levels of proinflammatory cytokines in the blood plasma, as well as reduced viral RNA titers in the lungs and hearts. Additionally, it reduced oxidative stress significantly and lessened the severity of interstitial pneumonia in the lungs when compared to infected positive controls.
The study concluded that equine-derived anti-SARS-CoV-2 antibodies could be used for COVID-19 prevention and treatment, especially in the early stages of the disease and in combination with antiviral drugs and vaccines. This treatment will benefit special patient populations such as immunocompromised individuals, as specific antibodies against SARS-CoV-2 can neutralize the virus before it enters host cells. The rapid and cost-effective production of the serum allows for its availability during the acute phase of the disease, making it a critical intervention in preventing the spread of the disease and saving lives in new variants where a vaccine is not yet developed.
Go to article

Bibliography

1. Botosso VF, Jorge SAC, Astray RM, Guimaraes AMS, Mathor MB, Carneiro PS, Durigon EL, Covas D, Oliveira DBL, Oliveira RN, Maria DA, Eto SF, Gallina NMF, Pidde G, Squaiella-Baptistão CS, Silva DT, Villas-Boas IM, Fernandes DC, Auada AVV, Banari AC, Filho AFS, Bianconi C, Utescher CLA, Oliveira DCA, Mariano DOC, Barbosa FF, Rondon G, Kapronezai J, Silva J G, Goldfeder MB, Comone P, Junior REC, Pereira TTS, Wen FH, Tambourgi DV, Chudzinski-Tavassi AM (2022) Anti-SARS-CoV-2 equine F (Ab′)2 immunoglobulin as a possible therapy for COVID-19. Sci Rep 12: 3890.
2. De Vito A, Colpani A, Saderi L, Puci M, Zauli B, Fiore V, Fois M, Meloni MC, Bitti A, Di Castri C, Maida I, Babudieri S, Sotgiu G, Madeddu G. (2022) Impact of early SARS-CoV-2 antiviral therapy on disease progression. Viruses 15: 71.
3. Dong W, Mead H, Tian L, Park JG, Garcia JI, Jaramillo S, Barr T, Kollath DS, Coyne VK, Stone NE, Jones A, Zhang J, Li A, Wang LS, Milanes-Yearsley M, Torrelles JB, Martinez-Sobrido L, Keim PS, Barker BM, Caligiuri MA, Yu J (2022) The K18-Human ACE2 transgenic mouse model recapitulates non-severe and severe COVID-19 in response to an infectious dose of the SARS-CoV-2 virus. J Virol: e0096421.
4. Golden JW, Cline CR, Zeng X, Garrison AR, Carey BD, Mucker EM, White LE, Shamblin JD, Brocato RL, Liu J, Babka AM, Rauch HB, Smith JM, Hollidge BS, Fitzpatrick C, Badger CV, Hooper JW (2020) Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease. JCI Insight 5: e142032.
5. Jha A, Barker D, Lew J, Manoharan V, Kessel JV, Haupt R, Toth D, Frieman M, Falzarano D, Kodihalli S (2022) Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection. Sci Rep 12: 16956.
6. León G, Herrera M, Vargas M, Arguedas M, Sánchez A, Segura A, Gómez A, Solano G, Aguilar E C, Risner K, Narayanan A, Bailey C, Villalta M, Hernández A, Sánchez A, Cordero D, Solano D, Durán G, Segura E, Cerdas M, Umaña D, Moscoso E, Estrada R, Gu-tiérrez J, Méndez M, Castillo AC, Sánchez L, Sánchez R, Gutiérrez JM, Díaz C, Alape A (2021) Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19. Sci Rep 11: 9825.
7. Li E, Han Q, Bi J, Wei S, Wang S, Zhang Y, Liu J, Feng N, Wang T, Wu J, Yang S, Zhao Y, Liu B, Yan F, Xia X (2023) Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection. Front Immunol 14: 1066730.
8. Luis Eduardo Cunha, Stolet AA, Strauch MA, Pereira VAR, Dumard CH, Gomes AMO, Souza PNC, Fonseca JG, Pontes FE, Meirelles LGR, Albuquerque JWM, Sacramento CQ, Rodrigues NF, Lima TM, Alvim RGF, Marsili FF, Caldeira MM, Higa LM, Monteiro FL, Zingali RB, Oliveira GAP, Souza TML, Tanuri A, Oliveira AC, Guedes H L M, Castilho L R , Silva J L (2020) Potent neutralizing equine antibodies raised against recombinant SARS-CoV-2 spike protein for COVID-19 passive immunization therapy. Cold Spring Harbor Laboratory, bioRxiv 17: 254375
9. Maccio U, Zinkernagel AS, Shambat SM, Zeng X, Cathomas G, Ruschitzka F, Schuepbach RA, Moch H, Varga Z. SARS-CoV-2 (2021) Leads to a small vessel endotheliitis in the heart. EBioMedicine 63: 103182.
10. Moreira-Soto A, Arguedas M, Brenes H, Buján W, Corrales-Aguilar E, Díaz C, Echeverri A, Flores-Díaz M, Gómez A, Hernández A, Herrera M, León G, Macaya R, Kühne A, Molina-Mora JA, Mora J, Sanabria A, Sánchez A, Sánchez L, Segura Á, Segura E, Solano D, Soto C, Stynoski JL, Vargas M, Villalta M, Reusken CBEM, Drosten C, Gutiérrez JM, Alape-Girón A, Drexler JF (2021) High efficacy of therapeutic equine hyperimmune antibodies against SARS-CoV-2 variants of concern. Frontiers in Medicine. 8: 735853.
11. Onen EA, Sonmez K, Yildirim F, Demirci EK, Gurel A (2022) Development, analysis, and preclinical evaluation of inactivated vaccine candidate for prevention of Covid-19 disease. All Life 15: 771-793.
12. Pan X, Zhou P, Fan T, Wu Y, Zhang J, Shi X, Shang W, Fang L, Jiang X, Shi J, Sun Y, Zhao S, Gong R, Chen Z, Xiao G (2020) Im-munoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro. Antiviral Res 182: 104868.
13. Schoell A, Heyde B, Weir D, Po-Chang C, Yiding H, Tung D (2009) Euthanasia method for mice in rapid time-course pulmonary. Pharmacokinetic Studies 48: 506.
14. Suvarna KS, Layton C, Bancroft JD (2018) Bancroft’s theory and practice of histological techniques E-Book. Elsevier health sciences, Philadelphia, pp 286-291.
15. Winkler ES, Bailey AL, Kafai NM, Nair S, McCune BT, Yu J, Fox JM, Chen RE, Earnest JT, Keeler SP, Ritter JH, Kang L, Dort S, Robichaud A, Head R, Holtzman MJ, Diamond MS (2020) SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat Immunol 21: 1327-1335.
16. Xu J, Xu X, Jiang L, Dua K, Hansbro PM, Liu G (2020) SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis. Respir Res 21: 182.
17. Yu P, Deng W, Bao L, Qu Y, Xu Y, Zhao W, Han Y, Qin C (2022) Comparative pathology of the nasal epithelium in K18-hACE2 Tg mice, hACE2 Tg mice, and hamsters infected with SARS-CoV-2. Vet Pathol 59: 602-612.
18. Zhang Q, Wang Y, Qi C, Shen L, Li J (2020) Clinical trial analysis of 2019-nCoV therapy registered in China. J Med Virol 92: 540-545.

Go to article

Authors and Affiliations

E.A. Onen
1
E.K. Demirci
2

  1. Kocak Pharmaceutical Company, Biotechnology and Vaccine R&D, Tekirdag, Turkey
  2. Histology and Embryology Department, Istanbul Faculty of Medicine,Istanbul University, Istanbul, Turkey

This page uses 'cookies'. Learn more